Metraipolis › archive › dc_b45bd7173e47

Strategic applications of heterocyclic compounds in pharmaceutical innovation: a business perspective — Europe PMC PMID:42131842

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42131842
DOI
10.3389/fchem.2026.1780357
License (as archived)
solo-consultazione
Archived
2026-10-07T15:50:41.533Z
SHA-256 of the archived text
4c3b8940f8235cc4a14ebefe531e3d54b70b34855d589d26f58672d71291c387
Stable URL of this page
https://metraipolis.com/documento/dc_b45bd7173e47

How to cite

Strategic applications of heterocyclic compounds in pharmaceutical innovation: a business perspective — Europe PMC PMID:42131842 — Europe PMC (en), https://europepmc.org/article/MED/42131842 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b45bd7173e47 (Metraipolis archive dc_b45bd7173e47, sha256 4c3b8940f8235cc4a14ebefe531e3d54b70b34855d589d26f58672d71291c387)
BibTeX
@misc{dcb45bd7173e47,
  title = {Strategic applications of heterocyclic compounds in pharmaceutical innovation: a business perspective — Europe PMC PMID:42131842},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42131842},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b45bd7173e47; sha256 4c3b8940f8235cc4a14ebefe531e3d54b70b34855d589d26f58672d71291c387},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42131842. Agents can read the archived copy with the MCP tool read_document.